The efficiency of antiviral therapy in patients with chronic hepatitis C infected with hepatitis C virus recombinants

The efficiency of antiviral therapy in patients with chronic hepatitis C infected with hepatitis C virus recombinants

The review gives the data available in the literature on the efficiency of treatment in patients with chronic hepatitis C infected with hepatitis C virus (HCV) recombinants, by applying various antiviral therapy regimens. The low efficiency of treatment with pegylated interferons (PEG IFN) + ribavir...

Full description

Bibliographic Details
Main Authors:	N D Yushchuk, O O Znoyko, K R Dudina, A N Kozina, O V Kalininа
Format:	Article
Language:	Russian
Published:	"Consilium Medicum" Publishing house 2016-06-01
Series:	Терапевтический архив
Subjects:	hepatitis c virus recombinants rf2k/1b chronic hepatitis c antiviral therapy ns5b sequencing
Online Access:	https://ter-arkhiv.ru/0040-3660/article/viewFile/32030/pdf

Similar Items

Analysis of ineffective antiviral therapy with pegylated interferon and ribavirin in a patient with chronic hepatitis C infected with HCV genotype 2
by: O O Znoyko, et al.
Published: (2016-05-01)

GENOME ORGANIZATION AND GEOGRAPHICAL DISTRIBUTION OF THE NATURAL INTERGENOTYPIC RECOMBINANT OF HEPATITIS C VIRUS RF1_2k/1b
by: O. V. Kalinina
Published: (2014-07-01)

Computational analysis of resistance mutations in the hepatitis C virus
by: Karina Salvatierra, et al.
Published: (2018-05-01)

Diagnosis of hepatitis C virus genotype 2k/1b needs NS5B sequencing
by: Steven De Keukeleire, et al.
Published: (2015-12-01)

Hepatitis C Viral Replication Complex
by: Hui-Chun Li, et al.
Published: (2021-03-01)

Possibilities of using cepeginterferon alpha-2b in double (cepeginterferon alfa-2b and ribavirin) and triple (simeprevir, cepeginterferon alpha-2b, and ribavirin) antiviral therapy regimens for chronic hepatitis C. A review of clinical trials and experience of everyday clinical practice
by: O O Znoyko, et al.
Published: (2016-11-01)

PREVALENCE OF HEPATITIS B AND HEPATITIS C AMONG PREOPERATIVE SURGICAL PATIENTS AT BASRAH GENERAL HOSPITAL
by: Mazin H AL-Hawaz, et al.
Published: (2014-06-01)

Direct-Acting Antivirals and the Risk of Hepatitis B Reactivation in Hepatitis B and C Co-Infected Patients: A Systematic Review and Meta-Analysis
by: Joo Hyun Oh, et al.
Published: (2022-11-01)

Biochemical Evolution and Histological Response of Patients with Hepatitis C Undergoing Antiviral Therapy.
by: Omar Julián Hernández Ojeda, et al.
Published: (2011-07-01)

Biochemical Evolution and Histological Response of Patients with Hepatitis C Undergoing Antiviral Therapy.
by: Omar Julián Hernández Ojeda, et al.
Published: (2011-07-01)

Impact of occult hepatitis B on the clinical outcomes of patients with chronic hepatitis C virus infection: A 10-year follow-up
by: Hsing-Yu Chen, et al.
Published: (2017-09-01)

Seroprevalence of Hepatitis B, Hepatitis C and HIV in Police School Students
by: Fatih TEMOÇİN, et al.
Published: (2017-09-01)

Hepatitis B and Hepatitis C in large vehicle drivers in center of Iran (Yazd)
by: Mohammadkazem Amirbeigy, et al.
Published: (2022-09-01)

Prevalence of Hepatitis ‘B’ and Hepatitis ‘C’ among preoperative cataract patients in Karachi
by: Naeem Syed, et al.
Published: (2012-09-01)

Frecuencia de hepatitis B y C en adultos con hemopatías malignas Frequency of hepatitis B and C in adults with malignant hemopathies
by: Catalino Ustáriz García, et al.
Published: (2005-04-01)

Hepatitis B and Hepatitis C Co-infection
by: Bircan KAYAASLAN, et al.
Published: (2015-09-01)

Occult hepatitis B infection and its possible impact on chronic hepatitis C virus infection
by: Habibollahi Peiman, et al.
Published: (2009-01-01)

Developments in small molecule antiviral drugs against hepatitis B and C viruses: FDA approved therapies and new drugs in clinical trials
by: Palak K. Parikh, et al.
Published: (2023-08-01)

Occult hepatitis B among Iranian hepatitis C patients
by: Ahmad shavakhi, et al.
Published: (2009-02-01)

Ultra-long-acting (XLA) antivirals for chronic viral hepatitis
by: Vicente Soriano, et al.
Published: (2022-01-01)

Hepatitis B vs. hepatitis C infection on viral hepatitis-associated hepatocellular carcinoma
by: Hiotis Spiros P, et al.
Published: (2012-06-01)

Intrafamilial seropositivity of hepatitis in patients with hepatitis B and C virus in hepatitis clinic in Hamadan, Iran
by: Mitra Ranjbar, et al.
Published: (2012-01-01)

The influence of hepatitis B virus on antiviral treatment with interferon and ribavirin in Asian patients with hepatitis C virus/hepatitis B virus coinfection: a meta-analysis
by: Liu Jun-Ying, et al.
Published: (2012-09-01)

A Systematic Review of the Frequency of Regulatory T Cells in Hepatitis B and Hepatitis C
by: Tri Nugraha Susilawati, et al.
Published: (2020-07-01)

Seroprevalence of Hepatitis B, Hepatitis C and HIV in Intensive Care Unit Patients
by: Hakan Bayır, et al.
Published: (2015-08-01)

Frequency of Hepatitis B and C Infection among Hemophiliac Patients in Kerman
by: M.J Zahedi, et al.
Published: (2004-07-01)

Hepatitis B y C en pacientes en hemodiálisis B and C hepatitis in patients with hemodialysis
by: Elba Patricia Cabezas Niubó, et al.
Published: (2010-01-01)

Recent Insights into the Role of B Cells in Chronic Hepatitis B and C Infections
by: Zgjim Osmani, et al.
Published: (2023-06-01)

Evaluation of hepatitis C, hepatitis B, and HIV virus Serology pandemic in thalassemia patients of Shahid Mohammadi Hospital of Bandar Abbas, Iran
by: Mohammad Aminianfar, et al.
Published: (2017-03-01)

Epidemiological study of hepatitis B and hepatitis C infections in Northeastern China and the beneficial effect of the vaccination strategy for hepatitis B: a cross-sectional study
by: Shishen Wang, et al.
Published: (2018-09-01)

Increased frequency of micronuclei in the lymphocytes of patients chronically infected with hepatitis B or hepatitis C virus
by: Samantha Therezinha Almeida Pereira Leite, et al.
Published: (2014-02-01)

Frecuencia de hepatitis B y C en niños con hemopatías malignas Frequency of hepatitis B and C with malignant hemopathies
by: Catalino Ustáriz García, et al.
Published: (2006-08-01)

Management of Hepatitis B Surface Antigen and Hepatitis C Antibody-Positive Patients by Departments Not Specializing in Hepatology at a Suburban University Hospital in Japan: A Single-Center Observational Study
by: Tokushima Y, et al.
Published: (2020-10-01)

Management of Hepatitis B Surface Antigen and Hepatitis C Antibody-Positive Patients by Departments Not Specializing in Hepatology at a Suburban University Hospital in Japan: A Single-Center Observational Study [Corrigendum]
by: Tokushima Y, et al.
Published: (2021-02-01)

Prevalence of hepatitis B and hepatitis C among blood donors in Baghdad, August 2007-December 2008.
by: Mariam K. Ali
Published: (2010-01-01)

Gilbert’s syndrome and antiviral therapy of hepatitis C
by: Katja Deterding, et al.
Published: (2009-07-01)

Seroprevalence of hepatitis B and C in the Western Brazilian Amazon region (Rio Branco, Acre): a pilot study carried out during a hepatitis B vaccination program
by: J. Tavares-Neto, et al.

HIV, hepatitis B, and hepatitis C in Zambia
by: Kenneth C Kapembwa, et al.
Published: (2011-01-01)

THE EFFICACY OF HEPATITIS B VACCINE IN HEMOPHILIC PATIENTS WITH HEPATITIS C VIRAL INFECTION
by: H HOUR FAR, et al.
Published: (2003-12-01)

WHO guidelines on testing for hepatitis B and C – meeting targets for testing
by: Margaret E. Hellard, et al.
Published: (2017-11-01)